Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα

Molecular Metabolism

Volumn 3, Issue 7, 2014, Pages 731-741

  Rutti, Sabine ^a   Arous, Caroline ^a   Schvartz, Domitille ^a   Timper, Katharina ^b   Sanchez, Jean Charles ^a   Dermitzakis, Emmanouil ^a   Donath, Marc Y ^b   Halban, Philippe A ^a   Bouzakri, Karim ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Inflammation; Insulin secretion; Insulin signaling pathway; Islets; Myokines; Survival

Indexed keywords

FRACTALKINE; GLUCAGON; INTERCELLULAR ADHESION MOLECULE 1; PAXILLIN; PROTEIN KINASE B; SORCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INSULIN RELEASE; MALE; MOLECULAR DYNAMICS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN TRANSPORT; PROTEOMICS; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84908139971     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.07.007     Document Type: Article

References (47)

1. Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 2013, 43(3):504-513.
2. Muller W.A., et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. New England Journal of Medicine 1970, 283(3):109-115.
3. Hotamisligil G.S., et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation 1995, 95(5):2409-2415.
4. Saghizadeh M., et al. The expression of TNF alpha by human muscle. Relationship to insulin resistance. Journal of Clinical Investigation 1996, 97(4):1111-1116.
5. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl. 2):97-101.
6. Mishima Y., et al. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2001, 52(2):119-123.
7. Winkler G., et al. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. Diabetes Research and Clinical Practice 1998, 42(3):169-174.
8. Kwon G., et al. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. Journal of Biological Chemistry 1999, 274(26):18702-18708.
9. Kim H.E., et al. Tumour necrosis factor-alpha-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca2+ influx. Journal of Endocrinology 2008, 198(3):549-560.
10. Bouzakri K., Ribaux P., Halban P.A. Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta-cells from TNF-alpha induced decrease of IRS2 and inhibition of glucose-stimulated insulin secretion. Journal of Biological Chemistry 2009, 150(12).
11. Garton K.J., et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). Journal of Biological Chemistry 2001, 276(41):37993-38001.
12. Hundhausen C., et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003, 102(4):1186-1195.
13. Aoyama T., et al. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 2010, 52(4):1390-1400.
14. Cardona A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nature Neuroscience 2006, 9(7):917-924.
15. Haskell C.A., Cleary M.D., Charo I.F. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. Journal of Biological Chemistry 1999, 274(15):10053-10058.
16. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arteriosclerosis Thrombosis and Vascular Biology 2008, 28(11):1897-1908.
17. Shah R., et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 2011, 60(5):1512-1518.
18. Bouzakri K., et al. Bimodal effect on pancreatic beta-cells of secretory products from normal or insulin-resistant human skeletal muscle. Diabetes 2011, 60(4):1111-1121.
19. Navarro-Gonzalez J.F., et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology 2011, 7(6):327-340.
20. Lee Y.S., et al. The fractalkine/CX3CR1 system regulates beta cell function and insulin secretion. Cell 2013, 153(2):413-425.
21. Parnaud G., et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008, 51(1):91-100.
22. Nica A.C., et al. Cell-type, allelic and genetic signatures in the human pancreatic beta cell transcriptome. Genome Research 2013, 23(9).
23. Rouiller D.G., Cirulli V., Halban P.A. Uvomorulin mediates calcium-dependent aggregation of islet cells, whereas calcium-independent cell adhesion molecules distinguish between islet cell types. Developmental Biology 1991, 148(1):233-242.
24. Tomas A., et al. Regulation of insulin secretion by phosphatidylinositol-4,5-bisphosphate. Traffic 2010, 11(1):123-137.
25. Dayon L., et al. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Analytical Chemistry 2008, 80(8):2921-2931.
26. Gluck F., et al. EasyProt - an easy-to-use graphical platform for proteomics data analysis. Journal of Proteomics 2013, 79:146-160.
27. Arous C., Rondas D., Halban P.A. Non-muscle myosin IIA is involved in focal adhesion and actin remodelling controlling glucose-stimulated insulin secretion. Diabetologia 2013, 56(4):792-802.
28. Rondas D., Tomas A., Halban P.A. Focal adhesion remodeling is crucial for glucose-stimulated insulin secretion and involves activation of focal adhesion kinase and paxillin. Diabetes 2011, 60(4):1146-1157.
29. Rutti S., et al. In vitro proliferation of adult human beta-cells. PLoS One 2012, 7(4):e35801.
30. Bouzakri K., et al. Rab GTPase-activating protein AS160 is a major downstream effector of protein kinase B/Akt signaling in pancreatic beta-cells. Diabetes 2008, 57(5):1195-1204.
31. Bouzakri K., Zierath J.R. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. Journal of Biological Chemistry 2007, 282(11):7783-7789.
32. Guntur K.V., et al. Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes. Journal of Biological Chemistry 2010, 285(9):6595-6603.
33. Plomgaard P., et al. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005, 54(10):2939-2945.
34. Noordeen N.A., et al. Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic beta-cells. Diabetes 2012, 61(3):574-585.
35. Cirulli V., Halban P.A., Rouiller D.G. Tumor necrosis factor-alpha modifies adhesion properties of rat islet B cells. Journal of Clinical Investigation 1993, 91(5):1868-1876.
36. Liu H., Jiang D. Fractalkine/CX3CR1 and atherosclerosis. Clinica Chimica Acta 2011, 412(13-14):1180-1186.
37. Jones B.A., Beamer M., Ahmed S. Fractalkine/CX3CL1: a potential new target for inflammatory diseases. Molecular Intervention 2010, 10(5):263-270.
38. Catoire M., et al. Identification of human exercise-induced myokines using secretome analysis. Physiological Genomics 2014, 46(7):256-267.
39. Wasserman D.H., et al. Exercise-induced fall in insulin and increase in fat metabolism during prolonged muscular work. Diabetes 1989, 38(4):484-490.
40. Wasserman D.H., et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. American Journal of Physiology 1989, 257(1 Pt 1):E108-E117.
41. Apostolakis S., Spandidos D. Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. Acta Pharmacologica Sinica 2013, 34(10):1251-1256.
42. Barlow A.D., Nicholson M.L., Herbert T.P. Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms. Diabetes 2013, 62(8):2674-2682.
43. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149(2):274-293.
44. Tesz G.J., et al. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. Journal of Biological Chemistry 2007, 282(27):19302-19312.
45. Parnaud G., et al. Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. Diabetes 2006, 55(5):1413-1420.
46. Farrell E.F., et al. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. Journal of Biological Chemistry 2003, 278(36):34660-34666.
47. Neerman-Arbez M., Sizonenko S.V., Halban P.A. Slow cleavage at the proinsulin B-chain/connecting peptide junction associated with low levels of endoprotease PC1/3 in transformed beta cells. Journal of Biological Chemistry 1993, 268(22):16098-16100.